4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 33 | 5 | 699 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -41 | 4.15 | 0 | -10 | -1 | 699 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | M.d | 0 | 0.00 | 0 | 9 | 115 | 17 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | S.d | -12 | 4.15 | 0 | -3 | -14 | 17 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | M.d | 0 | 0.00 | 0 | 9 | 3 | 349 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | S.d | -11 | 4.15 | 0 | -3 | -1 | 349 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Politi Jason | MA | O | Chief Te | M.d | 0 | 0.00 | 0 | 9 | 163 | 14 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Politi Jason | MA | O | Chief Te | S.d | -13 | 4.15 | 0 | -3 | -19 | 14 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 554 | 13 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -14 | 4.15 | 0 | -3 | -20 | 13 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/1/25 | VERV | Health | Drug | Pharmaceutical Preparations | Lister Troy | MA | O | Chief Sc | M.d | 0 | 0.00 | 0 | 7 | | 7 | D | | | | | | | | | | | | | | |
4/3/25 17:00 | 4/2/25 | VERV | Health | Drug | Pharmaceutical Preparations | Lister Troy | MA | O | Chief Sc | S.d | -9 | 4.15 | 0 | -2 | -24 | 7 | D | | | | | | | | | | | | | | |
12/3/24 16:30 | 11/29/24 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 53 | 5 | D | | | | | | | | | | | | | | |
12/3/24 16:30 | 12/2/24 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -3 | 5.64 | 0 | -1 | -9 | 5 | D | | | | | | | | | | | | | | |
7/2/24 07:30 | 6/28/24 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 86 | 2.87 | 0 | 30 | 5 | 673 | D | | | | | | | | | | | | | | |
5/15/24 17:30 | 5/14/24 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | P | 476 | 6.26 | 0 | 76 | 29 | 343 | D | | | | | | | | | | | | | | |
4/3/24 17:00 | 4/1/24 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | M.d | 0 | 0.00 | 0 | 3 | 62 | 9 | D | | | | | | | | | | | | | | |
4/3/24 17:00 | 4/2/24 | VERV | Health | Drug | Pharmaceutical Preparations | Nickerson Joan | MA | O | Chief Ad | S.d | -12 | 8.24 | 0 | -2 | -15 | 9 | D | | | | | | | | | | | | | | |
12/5/23 16:30 | 12/1/23 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | P | 18,000 | 10.00 | 0 | 1,800 | 17 | 12,168 | I | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 86 | 4 | D | | | | | | | | | | | | | | |
12/1/23 16:30 | 11/29/23 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -6 | 11.45 | 0 | -1 | -12 | 4 | D | | | | | | | | | | | | | | |
12/16/22 17:00 | 12/14/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 103 | 2.87 | 0 | 36 | 543 | 43 | D | | | | | | | | | | | | | | |
12/2/22 17:00 | 12/1/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S | -20 | 22.95 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | M.d | 0 | 0.00 | 0 | 2 | 603 | 2 | D | | | | | | | | | | | | | | |
12/1/22 17:00 | 11/29/22 | VERV | Health | Drug | Pharmaceutical Preparations | Dorval Allison | MA | O | CFO | S.d | -12 | 22.10 | 0 | -1 | -20 | 2 | D | | | | | | | | | | | | | | |
11/8/22 17:51 | 11/4/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S | -1,513 | 31.14 | 0 | -49 | 0 | 10,368 | I | | | | | | | | | | | | | | |
11/8/22 17:04 | 11/4/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S | -3,026 | 31.14 | 0 | -97 | -1 | 10,368 | I | | | | | | | | | | | | | | |
11/4/22 17:58 | 11/2/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S.m | -2,655 | 33.95 | 0 | -78 | -1 | 10,466 | I | | | | | | | | | | | | | | |
11/4/22 16:16 | 11/2/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S.m | -5,311 | 33.95 | 0 | -156 | -1 | 10,466 | I | | | | | | | | | | | | | | |
11/2/22 21:02 | 10/31/22 | VERV | Health | Drug | Pharmaceutical Preparations | Yeshwant Krishna | MA | DT | | S.m | -3,250 | 37.95 | 0 | -86 | -1 | 10,622 | I | | | | | | | | | | | | | | |
11/2/22 16:25 | 10/31/22 | VERV | Tech | Softw | Computer Programming, Data Pr | Gv 2017 Gp, L.L.C. | CA | H | Member o | S.m | -6,501 | 37.95 | 0 | -171 | -2 | 10,622 | I | | | | | | | | | | | | | | |
11/1/22 17:00 | 10/28/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 15 | 1.48 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
11/1/22 17:00 | 10/28/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -399 | 39.90 | 0 | -10 | -60 | 7 | D | | | | | | | | | | | | | | |
10/5/22 17:00 | 10/3/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
10/5/22 17:00 | 10/3/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,683 | 33.65 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
9/27/22 17:00 | 9/23/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 89 | 1.48 | 0 | 60 | | 7 | D | | | | | | | | | | | | | | |
9/27/22 17:00 | 9/23/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -2,120 | 35.34 | 0 | -60 | -90 | 7 | D | | | | | | | | | | | | | | |
8/29/22 17:00 | 8/25/22 | VERV | Health | Drug | Pharmaceutical Preparations | Ashe Andrew D. | MA | O | See Rema | M.d | 152 | 1.59 | 0 | 96 | 56 | 267 | D | | | | | | | | | | | | | | |
8/11/22 17:00 | 8/10/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
8/11/22 17:00 | 8/10/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,495 | 29.90 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
7/22/22 17:00 | 7/20/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 28 | 1.39 | 0 | 20 | | 7 | D | | | | | | | | | | | | | | |
7/22/22 17:00 | 7/20/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -698 | 34.90 | 0 | -20 | -75 | 7 | D | | | | | | | | | | | | | | |
7/21/22 17:00 | 7/19/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | M.d | 70 | 1.39 | 0 | 50 | 8 | 640 | D | | | | | | | | | | | | | | |
7/21/22 17:00 | 7/19/22 | VERV | Health | Drug | Pharmaceutical Preparations | Kathiresan Sekar | MA | DO | CEO | S.d | -1,495 | 29.90 | 0 | -50 | -7 | 640 | D | | | | | | | | | | | | | | |
7/15/22 17:00 | 7/13/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | M.d | 15 | 1.48 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
7/15/22 17:00 | 7/13/22 | VERV | Health | Drug | Pharmaceutical Preparations | Bellinger Andrew | MA | O | CSO,CMO | S.d | -249 | 24.90 | 0 | -10 | -60 | 7 | D | | | | | | | | | | | | | | |
7/14/22 17:24 | 7/12/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -3,387 | 20.78 | 0 | -163 | -22 | 571 | I | | | | | | | | | | | | | | |
7/6/22 12:56 | 7/1/22 | VERV | Health | Drug | Pharmaceutical Preparations | Fmr LLC | MA | TH | See Rema | S | -607 | 15.66 | 0 | -39 | -5 | 774 | I | | | | | | | | | | | | | | |